Compare KLAR & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KLAR | BCPC |
|---|---|---|
| Founded | 2005 | 1967 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.3B |
| IPO Year | 2023 | 1995 |
| Metric | KLAR | BCPC |
|---|---|---|
| Price | $12.13 | $163.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 25 | 3 |
| Target Price | $19.24 | ★ $213.50 |
| AVG Volume (30 Days) | ★ 6.6M | 215.6K |
| Earning Date | 11-17-2026 | 10-23-2026 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 4.09 |
| Revenue | N/A | ★ $799,023,000.00 |
| Revenue This Year | $18.47 | $9.17 |
| Revenue Next Year | $14.90 | $5.91 |
| P/E Ratio | ★ N/A | $40.48 |
| Revenue Growth | N/A | ★ 13.56 |
| 52 Week Low | $12.06 | $147.18 |
| 52 Week High | $33.10 | $186.15 |
| Indicator | KLAR | BCPC |
|---|---|---|
| Relative Strength Index (RSI) | 39.52 | 35.64 |
| Support Level | N/A | $160.38 |
| Resistance Level | $15.22 | $166.08 |
| Average True Range (ATR) | 0.78 | 3.97 |
| MACD | -0.07 | -1.32 |
| Stochastic Oscillator | 3.27 | 1.34 |
Klarna is the largest pure-play in the buy now, pay later space. The company operates a two-sided network with a payment method at its core, but it is ultimately a lender. Merchants sign up with Klarna to increase turnover in their stores. Primarily, Klarna can provide merchants with higher conversion rates and average order values relative to other payment methods. Some merchants enter a symbiotic relationship with Klarna, advertising its brand on the product page to drive conversion and to benefit from Klarna's brand value in the merchant's sales funnel. Customers use Klarna for its ease of use, quick access to credit, zero-interest financing, and lower reminder fees.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.